Idaho Senate Votes To Banish Cannabis Medicines
BOISE – Idaho’s Republican-dominated Senate have mustered the votes needed to pass a measure effectively banning cannabis in the Gem state with a 24-11 vote.
A proposed constitutional amendment that would prevent the legalization of pot and other psychoactive drugs has cleared the Idaho Senate and is headed to the House.
The Senate mustered the two-thirds needed with a 24-11 vote on Wednesday to approve a joint resolution that bans all psychoactive drugs not already legal in the state.
It will permanently ban medical cannabis for patients with terminal illnesses or chronic pain.
Backers say it’s needed because surrounding states have legalized pot and other drugs, and it could happen in Idaho.
If the House approves the legislation, it would go before voters in 2022, where it would need a simple majority. Republicans have super-majorities in the two chambers of the Idaho state government. Some Republican senators said they voted in favor of the amendment to simply allow voters to decide the issue at the ballot box.
Latest News
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...